Bone Cancers Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma
Condition:   Osteosarcoma Interventions:   Drug: Sulfatinib;   Drug: Etoposide;   Drug: Isophosphamide Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Chonnam National University;   Peking University People's Hospital;   Qilu Hospital of Shandong University;   Ruijin Hospital;   Shanghai Jiao Tong University Affiliated Sixth People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2022 Category: Research Source Type: clinical trials